Health and Fitness Health and Fitness
Mon, August 6, 2012
[ Mon, Aug 06th 2012 ] - Market Wire
Equity Research on CareFusion Corp. and Stryker C .. arnings Shake Up Medical Instruments and Supplies
[ Mon, Aug 06th 2012 ] - Market Wire
Positive Clinical Trial Results for Immunovaccine .. 07 Published in Journal of Translational Medicine
[ Mon, Aug 06th 2012 ] - Market Wire
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
[ Mon, Aug 06th 2012 ] - Market Wire
SearchCore Announces Executive Resignations
[ Mon, Aug 06th 2012 ] - Market Wire
Mylan Launches Generic Version of Amidate Injection
[ Mon, Aug 06th 2012 ] - Market Wire
EnteroMedics to Present at 32nd Annual Canaccord Genuity Growth Conference
[ Mon, Aug 06th 2012 ] - Market Wire
Luminex Corporation et l'h'pital universitaire du .. Galles s'associent l'occasion des Jeux olympiques
[ Mon, Aug 06th 2012 ] - Market Wire
Savient Pharmaceuticals Adopts Stockholder Rights Plan
[ Mon, Aug 06th 2012 ] - Market Wire
ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
[ Mon, Aug 06th 2012 ] - Market Wire
Sunshine Heart Announces Conditional Approval Fro .. for Its Next Generation C-Pulse(R) System Driver
Fri, August 3, 2012
[ Fri, Aug 03rd 2012 ] - Market Wire
Biostar Pharmaceuticals, Inc. Receives Approval F .. ng SFDA To Restart Sales Of Its Gel Capsule Drugs
[ Fri, Aug 03rd 2012 ] - Market Wire
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
[ Fri, Aug 03rd 2012 ] - Market Wire
DiaMedica Accelerates Warrant Expiry Date
[ Fri, Aug 03rd 2012 ] - Market Wire
Champions Oncology Reports Resignation Of Director
[ Fri, Aug 03rd 2012 ] - Market Wire
European Regulatory Authorities Approve Isis' Manufacturing Facility
[ Fri, Aug 03rd 2012 ] - Market Wire
SoloHealth and WellPoint Announce Strategic Relat .. lp Make Consumers More Aware, Empowered & Healthy
[ Fri, Aug 03rd 2012 ] - Market Wire
SoloHealth and WellPoint Announce Strategic Relat .. sumers More Aware, Empowered amp;; Healthy
[ Fri, Aug 03rd 2012 ] - Market Wire
Gemoscan Canada Announces Convertible Debenture Financing
[ Fri, Aug 03rd 2012 ] - Market Wire
Pro-Dex, Inc. Announces Update Conference Call and Webcast
[ Fri, Aug 03rd 2012 ] - Market Wire
Daxor Announces Sale of BVA-100 Blood Volume Analyzer and Payment of a Dividend
[ Fri, Aug 03rd 2012 ] - Market Wire
Avanir Pharmaceuticals Announces Listing Of Additional NUEDEXTA Patent In FDA Orange Book
[ Fri, Aug 03rd 2012 ] - Market Wire
Bioheart Renegotiates Company Note With Favorable Terms
[ Fri, Aug 03rd 2012 ] - Market Wire
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry
[ Fri, Aug 03rd 2012 ] - Market Wire
Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
Galapagos delivers solid half year results 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
Rosetta Genomics Announces Pricing of Public Offering of 5.5 Million Ordinary Shares
[ Thu, Aug 02nd 2012 ] - Market Wire
Accuray anuncia el primer Sistema CyberKnife en Sudamrica
[ Thu, Aug 02nd 2012 ] - Market Wire
MethylGene Reports Second Quarter 2012 Financial .. s and Provides an Update on its Clinical Programs
[ Thu, Aug 02nd 2012 ] - Market Wire
MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
[ Thu, Aug 02nd 2012 ] - Market Wire
Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012

Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012


Published on 2012-08-02 13:34:53 - Market Wire
  Print publication without navigation


August 02, 2012 16:15 ET

Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012

SAN FRANCISCO, CA--(Marketwire - Aug 2, 2012) - Medivation, Inc. (NASDAQ: [ MDVN ]) today announced that it will host a live teleconference with management to discuss second quarter 2012 financial results and provide a general business update on Thursday, August 9, 2012 at 4:30 p.m. Eastern Time. A press release for the second quarter of 2012 will be released after markets close on August 9, 2012.

Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at [ www.medivation.com ].


Contributing Sources